Targeted Molecular Imaging Agents for Cellular-Scale Bimodal Imaging
- 30 October 2004
- journal article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 15 (6) , 1488-1495
- https://doi.org/10.1021/bc049904q
Abstract
Molecular imaging is a powerful tool that has the ability to elucidate biochemical mechanisms and signal the early onset of disease. Overexpression of the peripheral benzodiazepine receptor (PBR) has been observed in a variety disease states, including glioblastoma, breast cancer, and Alzheimer's disease. Thus, the PBR could be an attractive target for molecular imaging. In this paper, the authors report cellular uptake and multimodal (MRI and fluorescence) imaging of PBR-overexpressing C6 glioblastoma (brain cancer) cells using a cocktail administration approach and a new PBR targeted lanthanide chelate molecular imaging agent.Keywords
This publication has 13 references indexed in Scilit:
- Facile, Efficient Conjugation of a Trifunctional Lanthanide Chelate to a Peripheral Benzodiazepine Receptor LigandOrganic Letters, 2002
- Mitochondria as a Pharmacological TargetPharmacological Reviews, 2002
- MMP-9 production by T cells from mammary tumor bearers is upregulated by tumor-derived VEGFBreast Cancer Research, 2001
- Location-dependent role of the human glioma cell peripheral-type benzodiazepine receptor in proliferation and steroid biosynthesisCancer Letters, 2000
- Sigma-2 receptors as a biomarker of proliferation in solid tumoursBritish Journal of Cancer, 2000
- Exploiting Differences in Sialoside Expression for Selective Targeting of MRI Contrast ReagentsJournal of the American Chemical Society, 1999
- Increased peripheral benzodiazepine binding sites in the brain of patients with Huntington's diseaseNeuroscience Letters, 1998
- PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitisJournal of Neuroscience Research, 1997
- Novel and Highly Potent 5-HT3 Receptor Agonists Based on a Pyrroloquinoxaline StructureJournal of Medicinal Chemistry, 1997
- Diazepam binding inhibitor is a paracrine/autocrine regulator of Leydig cell proliferation and steroidogenesis: action via peripheral-type benzodiazepine receptor and independent mechanisms.Endocrinology, 1993